Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MRSH
MRSH logo

MRSH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Marsh & McLennan Companies Inc (MRSH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
162.410
1 Day change
-1.10%
52 Week Range
193.320
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Based on the data provided, Marsh & McLennan Companies Inc (MRSH) does not present a compelling buy opportunity for a beginner investor with a long-term strategy. The stock lacks strong positive catalysts, has neutral trading sentiment, and no significant recent news or technical signals to suggest immediate upside potential. Analysts' ratings are mixed, with some downgrades in price targets, and Congress trading data shows balanced activity, indicating no strong insider conviction. Therefore, holding off on buying this stock is the recommended course of action.

Technical Analysis

The MACD histogram is positive but contracting, RSI is neutral at 37.842, and moving averages are converging. The stock is trading near its support level (S1: 161.894), suggesting limited downside but no clear bullish momentum. Overall, the technical indicators are neutral.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The options data shows a bearish sentiment with a high put-call volume ratio of 1.99, indicating more puts being traded than calls.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
2

Positive Catalysts

  • Congress trading data shows a recent purchase transaction, which could indicate some level of confidence. Additionally, the stock has a 70% chance of increasing by 0.94% in the next day and 4.15% in the next month.

Neutral/Negative Catalysts

  • Analysts have recently lowered price targets, citing sluggish organic growth in brokers. Options data indicates bearish sentiment, and there are no recent news catalysts to drive the stock higher. Hedge fund and insider trading trends are neutral, showing no strong conviction.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. Piper Sandler and Mizuho maintain Neutral ratings with lowered price targets, while Citi upgraded the stock to Buy, citing valuation opportunities. The average price target is trending lower, reflecting cautious sentiment in the sector.

Wall Street analysts forecast MRSH stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast MRSH stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 164.220
sliders
Low
0
Averages
0
High
0
0
Current: 164.220
sliders
Low
0
Averages
0
High
0
Piper Sandler
Paul Newsome
Neutral
downgrade
$190 -> $182
AI Analysis
2026-05-26
Reason
Piper Sandler
Paul Newsome
Price Target
$190 -> $182
AI Analysis
2026-05-26
downgrade
Neutral
Reason
Piper Sandler analyst Paul Newsome lowered the firm's price target on Marsh McLennan to $182 from $190 and keeps a Neutral rating on the shares. The firm cites recent stock performance and the roll-forward of time. In general, Piper has slightly raised price targets for most of the insurance carriers and reduced price targets for some of the insurance brokers. Its analysis tends to be bottom-up in its approach and following first quarter results, the firm thinks it is probably wise to focus on the carriers over the insurance brokers since underwriting performance in general was a better help than expected for the carriers and organic growth results for the broker.
Piper Sandler
Neutral
maintain
$190 -> $182
2026-05-26
Reason
Piper Sandler
Price Target
$190 -> $182
2026-05-26
maintain
Neutral
Reason
Piper Sandler lowered the firm's price target on Marsh McLennan to $182 from $190 and keeps a Neutral rating on the shares. The firm cites recent stock performance and the roll-forward of time. In general, Piper has slightly raised price targets for most of the insurance carriers and reduced price targets for some of the insurance brokers. Its analysis tends to be bottom-up in its approach and following first quarter results, the firm thinks it is probably wise to focus on the carriers over the insurance brokers since underwriting performance in general was a better help than expected for the carriers and organic growth results for the broker.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MRSH
Unlock Now

People Also Watch